NCAPH and neoplasm: MMTV‐NCAPHErbB2 double‐transgenic mice overexpressing NCAPH generated more aggressive breast tumours, and in a cohort of genetically heterogeneous transgenic mice generated by backcrossing, these tumours had a worse outcome and a poor response to chemotherapy.